These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 8034757)

  • 1. Presence of anti-CSL antibodies in the cerebrospinal fluid of patients: a sensitive and specific test in the diagnosis of multiple sclerosis.
    Zanetta JP; Tranchant C; Kuchler-Bopp S; Lehmann S; Warter JM
    J Neuroimmunol; 1994 Jul; 52(2):175-82. PubMed ID: 8034757
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies to cerebellar soluble lectin CSL in multiple sclerosis.
    Zanetta JP; Warter JM; Kuchler S; Marschal P; Rumbach L; Lehmann S; Tranchant C; Reeber A; Vincendon G
    Lancet; 1990 Jun; 335(8704):1482-4. PubMed ID: 1972431
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Presence of antibodies to lectin CSL in the blood of patients with multiple sclerosis patients].
    Zanetta JP; Warter JM; Lehmann S; Tranchant C; Kuchler S; Vincendon G
    C R Acad Sci III; 1990; 311(9):327-31. PubMed ID: 2128203
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Is Cerebellar Soluble Lectin a major immunological target in multiple sclerosis?].
    Zanetta JP; Warter JM; Lehmann S; Kuchler S; Vincendon G
    Pathol Biol (Paris); 1991 Jan; 39(1):7-11. PubMed ID: 2011413
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cerebrospinal fluid anti-cerebellar soluble lectin antibodies in human immunodeficiency virus type 1 infection.
    Hagberg L; Norkrans G; Zanetta JP; Lehmann S; Bergström T
    J Neuroimmunol; 1992 Feb; 36(2-3):245-9. PubMed ID: 1732284
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies against myelin oligodendrocyte glycoprotein in the cerebrospinal fluid of multiple sclerosis patients.
    Markovic M; Trajkovic V; Drulovic J; Mesaros S; Stojsavljevic N; Dujmovic I; Mostarica Stojkovic M
    J Neurol Sci; 2003 Jul; 211(1-2):67-73. PubMed ID: 12767500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding properties of cerebrospinal fluid IgG in multiple sclerosis and other neurological diseases.
    Page N; Perruisseau G; Steck AJ
    J Neurol Sci; 1983 Jul; 60(1):23-30. PubMed ID: 6192219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cerebrospinal fluid anti-cardiolipin antibodies in neurological diseases.
    Lolli F; Matá S; Baruffi MC; Amaducci L
    Clin Immunol Immunopathol; 1991 May; 59(2):314-21. PubMed ID: 2009647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibodies against the myelin oligodendrocyte glycoprotein and the myelin basic protein in multiple sclerosis and other neurological diseases: a comparative study.
    Reindl M; Linington C; Brehm U; Egg R; Dilitz E; Deisenhammer F; Poewe W; Berger T
    Brain; 1999 Nov; 122 ( Pt 11)():2047-56. PubMed ID: 10545390
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neurologic diseases and the cerebrospinal fluid immunoglobulin profile.
    Markowitz H; Kokmen E
    Mayo Clin Proc; 1983 Apr; 58(4):273-4. PubMed ID: 6834896
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibodies to myelin-associated glycoprotein (MAG) in the cerebrospinal fluid of multiple sclerosis patients.
    Möller JR; Johnson D; Brady RO; Tourtellotte WW; Quarles RH
    J Neuroimmunol; 1989 Mar; 22(1):55-61. PubMed ID: 2465313
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebrospinal fluid immune complexes in multiple sclerosis.
    Deicher H; Meyer zu Schwabedissen H; Baruth B; Patzold U; Haller P
    Experientia; 1979 Sep; 35(9):1249-50. PubMed ID: 488296
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibodies to the axolemma-enriched fraction in the cerebrospinal fluid and serum of patients with multiple sclerosis and other neurological diseases.
    Rawes JA; Calabrese VP; Khan OA; DeVries GH
    Mult Scler; 1997 Dec; 3(6):363-9. PubMed ID: 9493635
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibodies to myelin-oligodendrocyte glycoprotein in cerebrospinal fluid from patients with multiple sclerosis and controls.
    Xiao BG; Linington C; Link H
    J Neuroimmunol; 1991 Feb; 31(2):91-6. PubMed ID: 1991822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnostic value of cerebrospinal fluid myelin basic protein in patients with neurological illness.
    Davies L; McLeod JG; Muir A; Hensley WJ
    Clin Exp Neurol; 1987; 24():5-10. PubMed ID: 2478320
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The incidence and composition of oligoclonal immunoglobulins in the cerebrospinal fluid in multiple sclerosis and other neurologic diseases].
    Safár J; Vymazal J; Tichý J
    Cesk Neurol Neurochir; 1986 Nov; 49(6):374-81. PubMed ID: 2433060
    [No Abstract]   [Full Text] [Related]  

  • 17. Autoreactive T and B cells in nervous system diseases.
    Sun JB
    Acta Neurol Scand Suppl; 1993; 142():1-56. PubMed ID: 8382894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A correlation between cerebrospinal fluid myelin basic protein and anti-myelin basic protein in multiple sclerosis patients.
    Warren KG; Catz I
    Ann Neurol; 1987 Feb; 21(2):183-9. PubMed ID: 2435224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antioligodendrocyte antibodies in cerebrospinal fluid of multiple sclerosis and other neurologic diseases.
    Traugott U; Raine CS
    Neurology; 1981 Jun; 31(6):695-700. PubMed ID: 7017459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Components in multiple sclerosis cerebrospinal fluid that are detected by radioimmunoassay for myelin basic protein.
    Carson JH; Barbarese E; Braun PE; McPherson TA
    Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1976-8. PubMed ID: 77020
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.